Oxandrolone ( DrugBank: Oxandrolone )
2 diseases
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 211 | 左心低形成症候群 | 1 |
| 285 | ファンコニ貧血 | 1 |
211. 左心低形成症候群
臨床試験数 : 21 / 薬物数 : 29 - (DrugBank : 9) / 標的遺伝子数 : 5 - 標的パスウェイ数 : 14
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04090697 (ClinicalTrials.gov) | December 20, 2019 | 4/4/2019 | Use of Oxandrolone to Promote Growth in Infants With HLHS | Use of Oxandrolone to Promote Growth in Infants With Hypoplastic Left Heart Syndrome: A Phase I/II Pilot Study | Hypoplastic Left Heart;Congenital Heart Disease | Drug: Oxandrolone | HealthCore-NERI | NULL | Active, not recruiting | N/A | 14 Days | All | 25 | Phase 1/Phase 2 | United States;Canada |
285. ファンコニ貧血
臨床試験数 : 59 / 薬物数 : 118 - (DrugBank : 32) / 標的遺伝子数 : 31 - 標的パスウェイ数 : 155
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00243399 (ClinicalTrials.gov) | July 2004 | 20/10/2005 | Oxandrolone for the Treatment of Bone Marrow Aplasia in Fanconi Anemia | A Pilot Trial of Oxandrolone for the Treatment of Bone Marrow Aplasia in Patients With Fanconi Anemia | Fanconi Anemia | Drug: Oxandrolone | Children's Hospital Medical Center, Cincinnati | FDA Office of Orphan Products Development | Completed | N/A | N/A | Both | 10 | Phase 1 | United States |